SLC5A2 and hydrops fetalis: Given the cardiac anti-fibrotic effects of SGLT-2 inhibitors demonstrated in HF patients, as well as in experimental animal modes, we believe further research is needed in this area to explore potential therapies for preventing 5-FU-induced cardiotoxicity.